220 related articles for article (PubMed ID: 9388203)
1. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
Fraizer GC; Shimamura R; Zhang X; Saunders GF
J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
[TBL] [Abstract][Full Text] [Related]
2. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors.
Eccles MR; Yun K; Reeve AE; Fidler AE
Am J Pathol; 1995 Jan; 146(1):40-5. PubMed ID: 7856737
[TBL] [Abstract][Full Text] [Related]
3. Paired box gene expression in Wilms' tumor.
Tagge EP; Hanson P; Re GG; Othersen HB; Smith CD; Garvin AJ
J Pediatr Surg; 1994 Feb; 29(2):134-41. PubMed ID: 7909843
[TBL] [Abstract][Full Text] [Related]
4. Determination of functional domains of the human transcription factor PAX8 responsible for its nuclear localization and transactivating potential.
Poleev A; Okladnova O; Musti AM; Schneider S; Royer-Pokora B; Plachov D
Eur J Biochem; 1997 Aug; 247(3):860-9. PubMed ID: 9288908
[TBL] [Abstract][Full Text] [Related]
5. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
[TBL] [Abstract][Full Text] [Related]
6. Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors.
Poleev A; Wendler F; Fickenscher H; Zannini MS; Yaginuma K; Abbott C; Plachov D
Eur J Biochem; 1995 Mar; 228(3):899-911. PubMed ID: 7737192
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter.
Fraizer GC; Wu YJ; Hewitt SM; Maity T; Ton CC; Huff V; Saunders GF
J Biol Chem; 1994 Mar; 269(12):8892-900. PubMed ID: 8132626
[TBL] [Abstract][Full Text] [Related]
8. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
9. PAX8-mediated activation of the wt1 tumor suppressor gene.
Dehbi M; Pelletier J
EMBO J; 1996 Aug; 15(16):4297-306. PubMed ID: 8861958
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
12. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
13. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
[TBL] [Abstract][Full Text] [Related]
14. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
[TBL] [Abstract][Full Text] [Related]
15. Regulation of nov by WT1: a potential role for nov in nephrogenesis.
Martinerie C; Chevalier G; Rauscher FJ; Perbal B
Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864
[TBL] [Abstract][Full Text] [Related]
16. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture.
Scholz H; Bossone SA; Cohen HT; Akella U; Strauss WM; Sukhatme VP
J Biol Chem; 1997 Dec; 272(52):32836-46. PubMed ID: 9407061
[TBL] [Abstract][Full Text] [Related]
17. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
[TBL] [Abstract][Full Text] [Related]
18. Pax-2, kidney development, and oncogenesis.
Dressler GR
Med Pediatr Oncol; 1996 Nov; 27(5):440-4. PubMed ID: 8827071
[TBL] [Abstract][Full Text] [Related]
19. Repression of Pax-2 by WT1 during normal kidney development.
Ryan G; Steele-Perkins V; Morris JF; Rauscher FJ; Dressler GR
Development; 1995 Mar; 121(3):867-75. PubMed ID: 7720589
[TBL] [Abstract][Full Text] [Related]
20. Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.
Discenza MT; Dehbi M; Pelletier J
Nucleic Acids Res; 1997 Nov; 25(21):4314-22. PubMed ID: 9336463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
